Oncternal Therapeutics Inc.
ONCT | NASDAQ
$0.53
-$0.16 (-23.63%)
At close: Dec 02, 2024, 04:00 PM ET
-24.12%
(1Y)Key Statistics
Market Data
Market Cap $1.56M
1D Range
0.53 0.70
52W Range
0.53 10.61
Valuation (TTM)
PE -0.05
PB 0.17
EV/EBITDA 0.48
Valuation (NTM)
Forward PE N/A
Forward PEG -0.00
Price Target $28
Cash Flow
FCF Yield -1708.8%
SBC Adj. FCF Yield -2146.0%
SBC Impact -25.6%
Margins
Gross Margin -3690.2%
Operating Margin -2157.1%
FCF Margin -1597.6%
Growth (CAGR)
Revenue 3Y | 5Y -32.2% |
-5.1%
Dil EPS 3Y | 5Y -48.6% |
-54.3%
FCF 3Y | 5Y 12.1% |
-11.3%
Returns
ROA -107.5%
ROE 61.6%
ROIC -131.6%
Financial Health
Net Cash
$14.58M
Current Ratio 6.94
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
A detailed description of the company is not yet available.
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove ONCT